New drug trial aims to shrink painful lymphatic growths in kids and adults
NCT ID NCT05948943
First seen Jun 24, 2026 · Last updated Jul 15, 2026 · Updated 4 times
Summary
This study tests alpelisib, a drug that targets a specific gene mutation (PIK3CA), in people with lymphatic malformations—abnormal growths of lymph vessels. The trial includes children and adults and compares alpelisib to a placebo to see if it can shrink the growths and ease symptoms. Researchers are recruiting 232 participants across multiple sites.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- alpelisib (a targeted drug that blocks a specific protein called PI3K, which is overactive in these growths)
- What this could lead to
- If successful, this could provide a new treatment option to shrink lymphatic malformations and improve symptoms for people with PIK3CA mutations.
- What could go wrong
- This is an early-to-mid-stage trial, so results are not yet proven. The drug may cause side effects, and not all participants may respond.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHATIC MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College Of Medicine
RECRUITINGHouston, Texas, 77030, United States
-
CHOP Abramson Pediatric Resch Ctr
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Childrens Hosp Boston Dept of Heme
RECRUITINGBoston, Massachusetts, 02115, United States
-
Childrens Hosp Pittsburgh UPMC
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
-
Childrens Hospital and Regional Medical Center
RECRUITINGSeattle, Washington, 98105, United States
-
Childrens Hospital of Orange County
RECRUITINGOrange, California, 92868, United States
-
Childrens National Medical Center
RECRUITINGWashington D.C., District of Columbia, 20010-2970, United States
-
Cinn Children Hosp Medical Center
RECRUITINGCincinnati, Ohio, 45229-3039, United States
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
-
Lucile Packard Childrens Hosp
RECRUITINGPalo Alto, California, 94304, United States
-
Nationwide Children s Hospital
RECRUITINGColumbus, Ohio, 43205, United States
-
Nemours Childrens Clinic
RECRUITINGJacksonville, Florida, 32207, United States
-
Novartis Investigative Site
RECRUITINGCABA, Buenos Aires, C1181ACH, Argentina
-
Novartis Investigative Site
RECRUITINGCABA, Buenos Aires, C1425BEA, Argentina
-
Novartis Investigative Site
RECRUITINGCapital Federal, C1023AAB, Argentina
-
Novartis Investigative Site
RECRUITINGSydney, New South Wales, 2010, Australia
-
Novartis Investigative Site
RECRUITINGSydney, New South Wales, 2031, Australia
-
Novartis Investigative Site
RECRUITINGBrisbane, Queensland, 4101, Australia
-
Novartis Investigative Site
RECRUITINGBrussels, 1200, Belgium
-
Novartis Investigative Site
RECRUITINGBrno, 625 00, Czechia
-
Novartis Investigative Site
RECRUITINGAngers, 49933, France
-
Novartis Investigative Site
RECRUITINGBordeaux, 33076, France
-
Novartis Investigative Site
RECRUITINGBron, 69677, France
-
Novartis Investigative Site
RECRUITINGCaen, 14033, France
-
Novartis Investigative Site
RECRUITINGDijon, 21000, France
-
Novartis Investigative Site
RECRUITINGLille, 59000, France
-
Novartis Investigative Site
RECRUITINGMarseille, 13885, France
-
Novartis Investigative Site
RECRUITINGMontpellier, 34295, France
-
Novartis Investigative Site
RECRUITINGParis, 75010, France
-
Novartis Investigative Site
RECRUITINGParis, 75015, France
-
Novartis Investigative Site
RECRUITINGToulouse, 31054, France
-
Novartis Investigative Site
RECRUITINGTours, 37044, France
-
Novartis Investigative Site
RECRUITINGFreiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
Novartis Investigative Site
WITHDRAWNMannheim, Baden-Wurttemberg, 68305, Germany
-
Novartis Investigative Site
RECRUITINGCologne, North Rhine-Westphalia, 50937, Germany
-
Novartis Investigative Site
RECRUITINGLeipzig, Saxony, 04103, Germany
-
Novartis Investigative Site
RECRUITINGBerlin, 13353, Germany
-
Novartis Investigative Site
RECRUITINGUlm, 89081, Germany
-
Novartis Investigative Site
RECRUITINGBologna, BO, 40138, Italy
-
Novartis Investigative Site
RECRUITINGMilan, MI, 20122, Italy
-
Novartis Investigative Site
RECRUITINGRoma, RM, 00165, Italy
-
Novartis Investigative Site
RECRUITINGRoma, RM, 00168, Italy
-
Novartis Investigative Site
RECRUITINGTorino, TO, 10126, Italy
-
Novartis Investigative Site
RECRUITINGNaples, 80122, Italy
-
Novartis Investigative Site
RECRUITINGNijmegen, Gelderland, 6500HB, Netherlands
-
Novartis Investigative Site
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
-
Novartis Investigative Site
RECRUITINGPalma, Balearic Islands, 07120, Spain
-
Novartis Investigative Site
RECRUITINGEsplugues, Barcelona, 08950, Spain
-
Novartis Investigative Site
RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Novartis Investigative Site
RECRUITINGA Coruña, 15006, Spain
-
Novartis Investigative Site
RECRUITINGBarcelona, 08035, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28009, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28046, Spain
-
Novartis Investigative Site
RECRUITINGLausanne, 1011, Switzerland
-
Oregon Health Science University
RECRUITINGPortland, Oregon, 97239, United States
-
U of TX Health Science Ct
RECRUITINGHouston, Texas, 77030, United States
-
UCSF Benioff Children s Hospital
RECRUITINGOakland, California, 94609, United States
-
UNC Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
Univ Hospital Of Cleveland
RECRUITINGCleveland, Ohio, 44106, United States
-
WA Uni School Of Med
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill could shrink abnormal vessels in rare childhood disorders
- Which injection works best for Children's lymphatic malformations? new trial aims to find out
- New drug targets root cause of rare overgrowth syndromes
- Shrinking birthmarks: bleomycin injections show promise for cystic hygromas in kids